Editas Medicine (STU:8EM) Non Operating Income : €-0.01 Mil (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Editas Medicine Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Editas Medicine's Non Operating Income for the three months ended in Jun. 2024 was €-0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.01 Mil.

Editas Medicine Non Operating Income Historical Data

The historical data trend for Editas Medicine's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Editas Medicine Non Operating Income Chart

Editas Medicine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Non Operating Income

Get a 7-Day Free Trial

-0.12

13.37

0.03

1.22

-1.47

Editas Medicine Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Non Operating Income	Get a 7-Day Free Trial															-0.01	-	-0.01	0.01	-

Editas Medicine Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01 Mil.

Editas Medicine Non Operating Income Related Terms

Thank you for viewing the detailed overview of Editas Medicine's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Editas Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Editas Medicine Inc (STU:8EM) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

EDIT:USA 0IFK:UK 8EM:Germany

Address

11 Hurley Street, Cambridge, MA, USA, 02141

Website

https://www.editasmedicine.com

Editas Medicine Inc is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Editas Medicine Headlines

No Headlines